Willdan Group, Inc. (WLDN)
NASDAQ: WLDN · Real-Time Price · USD
85.33
+2.70 (3.27%)
Jul 31, 2025, 12:54 PM - Market open

Regulus Therapeutics Revenue

Willdan Group had revenue of $152.39M in the quarter ending April 4, 2025, with 24.41% growth. This brings the company's revenue in the last twelve months to $595.70M, up 12.40% year-over-year. In the year 2024, Willdan Group had annual revenue of $565.80M with 10.92% growth.

Revenue (ttm)
$595.70M
Revenue Growth
+12.40%
P/S Ratio
1.94
Revenue / Employee
$338,271
Employees
1,761
Market Cap
1.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 27, 2024565.80M55.70M10.92%
Dec 29, 2023510.10M80.96M18.87%
Dec 30, 2022429.14M75.38M21.31%
Dec 31, 2021353.76M-37.23M-9.52%
Jan 1, 2021390.98M-52.12M-11.76%
Dec 27, 2019 Pro Pro Pro
Dec 28, 2018 Pro Pro Pro
Dec 29, 2017 Pro Pro Pro
Dec 30, 2016 Pro Pro Pro
Jan 1, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition